Literature DB >> 15342958

Functional innervation in tissue engineered models for in vitro study and testing purposes.

Erik J Suuronen1, Christopher R McLaughlin, Peter K Stys, Masatsugu Nakamura, Rejean Munger, May Griffith.   

Abstract

The biotechnology industry is rapidly expanding and the emerging field of tissue engineering is projected to have a high impact in the near future. Recently the field of cellular, drug, and prosthetic delivery has melded with the field of tissue engineering to make simulated tissues. In addition to their roles as tissue substitutes for transplantation, these simulated tissues may provide more accurate models and environments for toxicology testing and the study of peripheral nerves. The current study demonstrates the importance of innervation, in general, for the function of engineered tissues. We observe that the presence of nerves in a tissue engineered (TE) human cornea model enhances the growth of the epithelium and the formation of its protective mucin layer. Innervation also confers protection to the epithelium from chemical insult, as determined by the level of post-treatment epithelial cell death. We demonstrate differential responses of the nerves to chemical stimuli by changes in intracellular sodium as measured by 2-photon microscopy. The 2-photon imaging techniques also allow for the visualization and study of the fine sensory axon fibers within the 3-dimensional tissue. This work demonstrates a role for innervation in the protective quality and function of the engineered tissue, and the potential to use the nerves themselves as indicators of the severity of an insult. These results are important to consider for the development of any optimized TE models for in vitro study and testing purposes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342958     DOI: 10.1093/toxsci/kfh270

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  16 in total

1.  Biosynthetic corneal substitute implantation in dogs.

Authors:  Ellison Bentley; Christopher J Murphy; Fengfu Li; David J Carlsson; May Griffith
Journal:  Cornea       Date:  2010-08       Impact factor: 2.651

Review 2.  Regenerative medicine: Current therapies and future directions.

Authors:  Angelo S Mao; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

3.  Producing organs in the laboratory.

Authors:  Mark E Furth; Anthony Atala
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

4.  Effects of reduced oxygen and glucose levels on ocular cells in vitro: implications for tissue models.

Authors:  Edward A Sander; Eric A Nauman
Journal:  Cells Tissues Organs       Date:  2009-07-28       Impact factor: 2.481

Review 5.  In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.

Authors:  Yulia Kaluzhny; Mitchell Klausner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-05       Impact factor: 2.416

6.  In vitro 3D corneal tissue model with epithelium, stroma, and innervation.

Authors:  Siran Wang; Chiara E Ghezzi; Rachel Gomes; Rachel E Pollard; James L Funderburgh; David L Kaplan
Journal:  Biomaterials       Date:  2016-10-04       Impact factor: 12.479

7.  Bridging the Divide between Neuroprosthetic Design, Tissue Engineering and Neurobiology.

Authors:  Jennie B Leach; Anil Kumar H Achyuta; Shashi K Murthy
Journal:  Front Neuroeng       Date:  2010-02-08

Review 8.  Bioengineering strategies to accelerate stem cell therapeutics.

Authors:  Christopher M Madl; Sarah C Heilshorn; Helen M Blau
Journal:  Nature       Date:  2018-05-16       Impact factor: 49.962

9.  Tissue engineering: current strategies and future directions.

Authors:  Jennifer L Olson; Anthony Atala; James J Yoo
Journal:  Chonnam Med J       Date:  2011-04-26

10.  Control of scar tissue formation in the cornea: strategies in clinical and corneal tissue engineering.

Authors:  Samantha L Wilson; Alicia J El Haj; Ying Yang
Journal:  J Funct Biomater       Date:  2012-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.